» Articles » PMID: 26003310

Prevalence of Chronic Pulmonary Aspergillosis in Patients with Tuberculosis from Iran

Overview
Publisher Springer
Date 2015 May 25
PMID 26003310
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with preexisting lung disease, especially a cavity, Aspergillus can infect the surface of the cavity, causing chronic cavitary pulmonary aspergillosis (CCPA), and may form an aspergilloma, collectively called chronic pulmonary aspergillosis (CPA). In the present study, we assessed tuberculosis (TB) patients for CPA based on culture and serological methods. During a period of 1 year (from March 2013 to March 2014), we studied 124 patients with TB (94 with current TB and 30 with previous TB) at Masih Daneshvari Hospital in Tehran, Iran. Sputum specimens were analyzed by direct microscopic examination (DME) and fungal culture. The clinical and radiological features of all patients were recorded, to categorize the patients into CCPA and aspergilloma. All patients were screened for serum-specific IgG against A. fumigatus, by enzyme-linked immunosorbent assay (ELISA). Out of 124 patients with TB (66 male, age range: 10-91 years), 48 patients (38.7 %) exhibited residual cavities. Eighteen (14.5 %) patients had cavities with pleural thickening. A round-shaped mass lesion was detected in six patients (6.8 %). DME was positive in ten patients for septate fungal hyphae. A. fumigatus was grown from 14 samples. Fifty-five (44.3 %) cases were positive for serum-specific IgG against A. fumigatus. Of 124 patients with TB, 3 (2.4 %) met criteria for aspergilloma and 14 (11.3 %) for CCPA. CPA is a common clinical presentation in individuals with healed TB in Iran, as reported by previous studies from other countries.

Citing Articles

Successful treatment of chronic pulmonary aspergillosis in a patient with early pulmonary tuberculosis and COVID-19: a case report.

Bertucci A, Volpe-Chaves C, Mendo D, Andrade U, Lacerda M, Venturini J Multidiscip Respir Med. 2024; 19.

PMID: 39636397 PMC: 11661397. DOI: 10.5826/mrm.2024.989.


Prevalence of Chronic Pulmonary Aspergillosis in Two (2) Tuberculosis Treatment Clinics in Lagos, Nigeria: A Prospective Longitudinal Study.

Davies A, Adekoya A, Balogun O, Osaigbovo I, Nwosu A, Gbaja-Biamila T Open Forum Infect Dis. 2024; 11(4):ofae090.

PMID: 38567195 PMC: 10986852. DOI: 10.1093/ofid/ofae090.


Prevalence of chronic pulmonary aspergillosis along the continuum of pulmonary tuberculosis care: A protocol for a living systematic review and meta-analysis.

Bongomin F, Olum R, Kibone W, Namusobya M, van Rhijn N, Denning D PLoS One. 2023; 18(12):e0294634.

PMID: 38100446 PMC: 10723662. DOI: 10.1371/journal.pone.0294634.


Mycologically confirmed chronic pulmonary aspergillosis in a post-pulmonary tuberculosis patient in Ghana.

Ocansey B, Adjei A, Denning D Ghana Med J. 2023; 56(4):336-339.

PMID: 37575628 PMC: 10416292. DOI: 10.4314/gmj.v56i4.13.


Prevalence and predictors of Aspergillus seropositivity and chronic pulmonary aspergillosis in an urban tertiary hospital in Sierra Leone: A cross-sectional study.

Lakoh S, Kamara J, Orefuwa E, Sesay D, Jiba D, Adekanmbi O PLoS Negl Trop Dis. 2023; 17(7):e0011284.

PMID: 37459359 PMC: 10374077. DOI: 10.1371/journal.pntd.0011284.


References
1.
Camuset J, Nunes H, Dombret M, Bergeron A, Henno P, Philippe B . Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 2007; 131(5):1435-41. DOI: 10.1378/chest.06-2441. View

2.
Kurhade A, Deshmukh J, Fule R, Chande C, Akulwar S . Mycological and serological study of pulmonary aspergillosis in central India. Indian J Med Microbiol. 2007; 20(3):141-4. View

3.
Shirai M, Hayakawa H, Uchiyama H, Chida K, Nakamura H . Clinical significance of potential pathogenic microorganisms of sputum in patients with pulmonary tuberculosis. Respirology. 2002; 6(4):311-5. DOI: 10.1046/j.1440-1843.2001.00349.x. View

4.
Vahid B, Marik P . Fatal massive hemoptysis in a patient on low-dose oral prednisone: chronic necrotizing pulmonary aspergillosis. Respir Care. 2007; 52(1):56-8. View

5.
Kosmidis C, Denning D . The clinical spectrum of pulmonary aspergillosis. Thorax. 2014; 70(3):270-7. DOI: 10.1136/thoraxjnl-2014-206291. View